Doerfler Douglas's Form 4 filing
Maxcyte, Inc. (MXCT) · filed May 5, 2023
- Accession no.
- 0001209191-23-027781
- Filed
- May 5, 2023, 5:09 PM ET
- Trade date
- May 3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $81.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Doerfler DouglasCIK 0001874482 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | Common Stock | MOption exerciseAcquired | +16,149 | $0.04 | +$645.96 | 349,346 | Direct | |
| May 3, 2023 | Common Stock | SSaleDisposed | −16,149 | $5.02 | −$81,067.98 | 333,197 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | Common Stock | MOption exerciseDisposed | −16,149 | $0.00 | $0 | 308,931 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.